Catalent has signed an agreement with Spicona to develop a virus-like protein (VLP)-based vaccine against COVID-19. Read more...
FDA Issues EUA for ChromaCode's HDPCR™ SARS-CoV-2 Real-Time PCR Assay
ChromaCode announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) of ChromaCode's HDPCR™ SARS-CoV-2 Real-Time PCR Assay. Read more...
HealthVerity has signed a multi-year Research Collaboration Agreement with the U.S. Food and Drug Administration (FDA) to evaluate a range of different real-world datasets for their potential to inform the FDA's response to COVID-19. Read more...